Literature DB >> 28154192

Streptococcus pyogenes Endopeptidase O Contributes to Evasion from Complement-mediated Bacteriolysis via Binding to Human Complement Factor C1q.

Mariko Honda-Ogawa1, Tomoko Sumitomo1, Yasushi Mori1,2, Dalia Talat Hamd1, Taiji Ogawa3, Masaya Yamaguchi1, Masanobu Nakata1, Shigetada Kawabata4.   

Abstract

Streptococcus pyogenes secretes various virulence factors for evasion from complement-mediated bacteriolysis. However, full understanding of the molecules possessed by this organism that interact with complement C1q, an initiator of the classical complement pathway, remains elusive. In this study, we identified an endopeptidase of S. pyogenes, PepO, as an interacting molecule, and investigated its effects on complement immunity and pathogenesis. Enzyme-linked immunosorbent assay and surface plasmon resonance analysis findings revealed that S. pyogenes recombinant PepO bound to human C1q in a concentration-dependent manner under physiological conditions. Sites of inflammation are known to have decreased pH levels, thus the effects of PepO on bacterial evasion from complement immunity was analyzed in a low pH condition. Notably, under low pH conditions, PepO exhibited a higher affinity for C1q as compared with IgG, and PepO inhibited the binding of IgG to C1q. In addition, pepO deletion rendered S. pyogenes more susceptible to the bacteriocidal activity of human serum. Also, observations of the morphological features of the pepO mutant strain (ΔpepO) showed damaged irregular surfaces as compared with the wild-type strain (WT). WT-infected tissues exhibited greater severity and lower complement activity as compared with those infected by ΔpepO in a mouse skin infection model. Furthermore, WT infection resulted in a larger accumulation of C1q than that with ΔpepO. Our results suggest that interaction of S. pyogenes PepO with C1q interferes with the complement pathway, which enables S. pyogenes to evade complement-mediated bacteriolysis under acidic conditions, such as seen in inflammatory sites.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  C1Q complex (C1QA); Streptococcus pyogenes (S. pyogenes); complement system; innate immunity; peptidase

Mesh:

Substances:

Year:  2017        PMID: 28154192      PMCID: PMC5354489          DOI: 10.1074/jbc.M116.749275

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution.

Authors:  Ichiro Nakagawa; Ken Kurokawa; Atsushi Yamashita; Masanobu Nakata; Yusuke Tomiyasu; Nobuo Okahashi; Shigetada Kawabata; Kiyoshi Yamazaki; Tadayoshi Shiba; Teruo Yasunaga; Hideo Hayashi; Masahira Hattori; Shigeyuki Hamada
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

2.  alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface.

Authors:  S Bergmann; M Rohde; G S Chhatwal; S Hammerschmidt
Journal:  Mol Microbiol       Date:  2001-06       Impact factor: 3.501

Review 3.  Physiologic role of the complement system in host defense, disease, and malnutrition.

Authors:  M Sakamoto; Y Fujisawa; K Nishioka
Journal:  Nutrition       Date:  1998-04       Impact factor: 4.008

4.  α-Enolase of Streptococcus pneumoniae induces formation of neutrophil extracellular traps.

Authors:  Yuka Mori; Masaya Yamaguchi; Yutaka Terao; Shigeyuki Hamada; Takashi Ooshima; Shigetada Kawabata
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

Review 5.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

6.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

Authors:  R D Horstmann; H J Sievertsen; J Knobloch; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Characterization of a streptococcal endopeptidase with homology to human endothelin-converting enzyme.

Authors:  J Oetjen; P Fives-Taylor; E Froeliger
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

8.  Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors.

Authors:  Mariko Honda-Ogawa; Taiji Ogawa; Yutaka Terao; Tomoko Sumitomo; Masanobu Nakata; Kazunori Ikebe; Yoshinobu Maeda; Shigetada Kawabata
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

9.  Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells.

Authors:  Vaibhav Agarwal; Arunakar Kuchipudi; Marcus Fulde; Kristian Riesbeck; Simone Bergmann; Anna M Blom
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

Review 10.  Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.

Authors:  Roberto Castelli; Andrea Zanichelli; Massimo Cugno
Journal:  Immunopharmacol Immunotoxicol       Date:  2013-02       Impact factor: 2.730

View more
  9 in total

1.  Endopeptidase PepO Regulates the SpeB Cysteine Protease and Is Essential for the Virulence of Invasive M1T1 Streptococcus pyogenes.

Authors:  Stephan Brouwer; Amanda J Cork; Cheryl-Lynn Y Ong; Timothy C Barnett; Nicholas P West; Kevin S McIver; Mark J Walker
Journal:  J Bacteriol       Date:  2018-03-26       Impact factor: 3.490

2.  Gene fitness landscape of group A streptococcus during necrotizing myositis.

Authors:  Luchang Zhu; Randall J Olsen; Stephen B Beres; Jesus M Eraso; Matthew Ojeda Saavedra; Samantha L Kubiak; Concepcion C Cantu; Leslie Jenkins; Amelia R L Charbonneau; Andrew S Waller; James M Musser
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

3.  Streptococcus endopeptidases promote HPV infection in vitro.

Authors:  Sylvia I Pavlova; Reid V Wilkening; Michael J Federle; Yu Lu; Joel Schwartz; Lin Tao
Journal:  Microbiologyopen       Date:  2018-04-19       Impact factor: 3.139

4.  PepO is a target of the two-component systems VicRK and CovR required for systemic virulence of Streptococcus mutans.

Authors:  Lívia A Alves; Tridib Ganguly; Érika N Harth-Chú; Jessica Kajfasz; José A Lemos; Jacqueline Abranches; Renata O Mattos-Graner
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

5.  Complement evasion factor (CEF), a novel immune evasion factor of Streptococcus pyogenes.

Authors:  Haniyeh Aghababa; Yi Tian Ting; Devaki Pilapitiya; Jacelyn M S Loh; Paul G Young; Thomas Proft
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

6.  Protease activities of vaginal Porphyromonas species disrupt coagulation and extracellular matrix in the cervicovaginal niche.

Authors:  Karen V Lithgow; Vienna C H Buchholz; Emily Ku; Shaelen Konschuh; Ana D'Aubeterre; Laura K Sycuro
Journal:  NPJ Biofilms Microbiomes       Date:  2022-02-21       Impact factor: 7.290

7.  Binding of Plasminogen to Streptococcus suis Protein Endopeptidase O Facilitates Evasion of Innate Immunity in Streptococcus suis.

Authors:  Yang Zhou; Kang Yan; Chengfeng Sun; Feng Liu; Wei Peng; Huanchun Chen; Fangyan Yuan; Weicheng Bei; Jinquan Li
Journal:  Front Microbiol       Date:  2021-07-08       Impact factor: 5.640

8.  The Surface-Exposed Protein SntA Contributes to Complement Evasion in Zoonotic Streptococcus suis.

Authors:  Simin Deng; Tong Xu; Qiong Fang; Lei Yu; Jiaqi Zhu; Long Chen; Jiahui Liu; Rui Zhou
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

9.  Exploration of Survival Traits, Probiotic Determinants, Host Interactions, and Functional Evolution of Bifidobacterial Genomes Using Comparative Genomics.

Authors:  Vikas Sharma; Fauzul Mobeen; Tulika Prakash
Journal:  Genes (Basel)       Date:  2018-10-01       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.